The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.
about
Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptorsIRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humansFunctional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cellsMolecular mechanisms of autoimmunity triggered by microbial infection.CpG Oligonucleotides as Cancer Vaccine AdjuvantsTranslating transitions - how to decipher peripheral human B cell developmentDifferential impact of Toll-like receptor signaling on distinct B cell subpopulationsAutoantibodies in systemic autoimmune diseases: specificity and pathogenicityPremature B-cell senescence as a consequence of chronic immune activation.IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patientsThe largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.A conserved gene family encodes transmembrane proteins with fibronectin, immunoglobulin and leucine-rich repeat domains (FIGLER).B cell activation by outer membrane vesicles--a novel virulence mechanismTLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patientsIdentification of B cells through negative gating-An example of the MIFlowCyt standard applied.Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells.Toll-like receptors regulate B cell cytokine production in patients with diabetes.Toll-like receptor 7 and 9 defects in common variable immunodeficiency.The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferationIn situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyMantle cell lymphoma activation enhances bortezomib sensitivity.Differential regulation of TLR4 expression in human B cells and monocytes.Microfluidic squeezing for intracellular antigen loading in polyclonal B-cells as cellular vaccinesRevisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.TLR10 Is a B Cell Intrinsic Suppressor of Adaptive Immune Responses.Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantationViral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach.Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway.Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphomaToll-like receptors and myocardial inflammation.Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsAntigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infectionImprovement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
P2860
Q24299913-F2C485D3-65F7-4E45-B017-974B1EACFB08Q24314442-9E464666-8391-446D-B20F-A3E1342F685AQ24645351-5A5FC9D8-9DB6-4C2D-8EF3-C3EA577F81F8Q24812576-EE87E899-80E6-4425-8202-56A458560252Q26783826-2D5CE4E5-F064-4FD5-9E91-08D2DA895275Q26799037-2E1E450A-AD3B-4196-8EDA-B017044137D1Q26825241-2B6260EA-53E9-4E5D-B828-E71329268949Q27024588-60159CA4-2C1A-4D90-9FC2-7D14FCD700EAQ27693281-CD4E01C8-A274-463C-8CF8-9503883DEDEBQ28710292-3488ACD7-2882-4D5D-9D96-6200957032D5Q31089201-8DE4A0AD-9771-49E2-BC1F-12A8F76E58A7Q33298840-A069EC03-41C4-44AD-8F34-B6857D1BD9FDQ33525515-4A090688-C117-486A-A82A-013CB687C009Q33775405-3374D75F-0B76-43AB-9181-E03EB3BA9B21Q33886075-40C8B9E0-158D-4D65-A67A-712A33C968E5Q33931707-F9810D78-3D09-4912-93C6-68AC5BD00720Q33954398-602BDD6A-D458-4E38-BF1A-1EB4128F9610Q34013669-90BA4123-1F9C-4A61-BA51-4ECF07390B7EQ34088209-2609F695-E513-4A41-8095-3402E5DABDB0Q34194680-7CFEF2B3-4C11-49B3-9317-1010CA588835Q34360347-2334DEAA-6F54-46FF-BB08-BD7FAE8B3221Q34361049-8A66220B-EAC9-4076-8B16-D44DF66AFF00Q34477358-A51FFC04-F4F0-4676-A13E-E5AD59F61599Q34495557-1338A432-5BE4-4E14-9DF3-E7B37FD573D8Q34547201-56F5C710-C930-432D-8574-00B9ECBEDD18Q34574238-CCF106CC-8DAD-45EA-92B8-2EB7C4D2AD73Q34613585-B6918C69-A685-40C3-BB2B-DC483317B6B8Q34618829-2D5B0DA7-011B-4ACB-8EC0-C600AFE7F9C7Q34624625-00CAAC64-9339-41E3-886E-6410236AD741Q34631422-BC19DC9C-A617-4CBB-BD9D-6DDC8E54F7BBQ34650870-E31BF60B-81F1-41AD-9D72-5C5645AFF2A7Q34673706-C478EB59-E28C-424F-ADB0-7150B2600B01Q35080072-03121648-9C43-4852-808D-2B43ABBF4E61Q35154940-B05AD139-A9A0-4B86-8582-B13177A45E78Q35240118-EA2D5F52-E3C9-4767-8762-CD65D5F27781Q35528659-83B78134-D101-4860-9359-5C44EDC40C41Q35531527-F18850CF-34D9-4492-9963-6F0E88DE4E70Q35940728-CF9B3322-05B5-4EE7-A405-5FA80ABD5909Q35971414-058E2C65-691B-4673-83E6-665889E9399FQ36071989-D9A7274C-DC80-4DC9-AFFD-1E295E9F7C06
P2860
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The toll-like receptor reperto ...... normal and transformed cells.
@en
type
label
The toll-like receptor reperto ...... normal and transformed cells.
@en
prefLabel
The toll-like receptor reperto ...... normal and transformed cells.
@en
P50
P1433
P1476
The toll-like receptor reperto ...... normal and transformed cells.
@en
P2093
Daniela Bosisio
Nadia Polentarutti
P304
P356
10.1182/BLOOD-2002-11-3355
P407
P577
2003-04-10T00:00:00Z